IHH Healthcare posts net profit of RM236.34m in Q3

 Publish date: Fri, 29 Nov 2019, 8:49 PM

KUALA LUMPUR: IHH Healthcare Bhd posted a net profit of RM236.34 million for the third quarter ended Sept 30, 2019 (Q3) compared with a net loss of RM104.07 million in the same quarter last year.

In a filing to the stock exchange, the global healthcare provider said revenue rose 33 per cent to RM3.79 billion from RM2.84 billion previously.

It said revenue improved on sustained organic growth at existing operations and contributions from Gleneagles Hong Kong Hospital and Acibadem Altunizade Hospital in Turkey, both opened in March 2017.

For the first nine-month period, net profit jumped to RM510.85 million from RM118.27 million, while revenue increased 33 per cent to RM11.08 billion from RM8.35 billion.

IHH said the group's balance sheet remained strong as of end-September, with net cash generated from operating activities for the nine months at RM1.7 billion and an overall cash balance of RM4.6 billion.

Net gearing edged up to 0.15 times versus 0.10 times as at Dec 31, 2018, on strategic investments including Fortis in India.

IHH chief executive officer (designate) and executive director Dr Kelvin Loh said prioritising operational synergies and integration produced a strong set of third-quarter results.

He pointed out that the proposed acquisition of Prince Court Medical Centre was set to enhance its leadership position in Malaysia.

Moreover, IHH's proactive stance to recalibrate non-lira loans in Acibadem had also reduced its exposure to currency volatility.

"In India, Fortis delivered another impressive performance as we continue to see healthy momentum with an improvement to its operational profitability in both the hospital and diagnostics business.

"We're also excited with our progress in Greater China, where we have just opened Gleneagles Chengdu," Loh said in a statement, adding that IHH would continue to ramp up operations at Gleneagles Hong Kong amidst steady demand.

Moving forward, IHH plans to further consolidate its multi-country portfolio strategy to diversify its earnings base in cashflow-generative markets such as Singapore and Malaysia, capture medium-term growth momentum from Turkey and long-term growth opportunities from India and Greater China.


Share this

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View Trading Signals and run Live Backtest
MQ Affiliate
Earn rewards with MQ Affiliate Program

430  455  537  679 

Top 10 Active Counters
 XOX 0.175+0.005 
 MTRONIC 0.085+0.005 
 VSOLAR 0.040.00 
 ASB 0.15-0.025 
 KANGER 0.205-0.015 
 BINTAI 0.69-0.015 
 PTRANS 0.2850.00 
 JCY 0.755+0.04 
 INIX 0.33+0.03 
 KSTAR 0.20+0.02 


1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!


1. SUPERMAX: High Court to hear former Supermax MD Stanley Thai's appeal on Sept 29 Van Gogh of Financial
2. TOPGLOV (7113) - Top Glove spent RM 354,738,027.11 in September for Share Buyback !!! Good or Bad? Bursa Malaysia Free Trading Education
3. KLCI waves 26 - Wave 3 could have started KLCI waves
4. Call Warrants on HARTA / KOSSAN / SUPERMX / TOPGLOV, My pick is HARTA-C54 i3gambler
5. Why do most equity investors lose money? Koon Yew Yin Koon Yew Yin's Blog
6. A Test Drives Day With My Uncle (Retired Fund Manager) Learn from my Uncle (Retired Fund Manager)
7. 顶级手套拉锯战/万年船 小股东大权利
8. 顶级手套业绩超越Maybank!股价却没反应,因为有一样东西悄悄地发生了变化!(Part 1/4) Valuation on Glove Sector - 陈剑 Good Articles to Share